Catalyst Watch: FOMC Meeting, Govt. Funding Drama, Earnings for Micron, Nike, and FedEx

Seeking AlphaDec 13 15:00 ET

IDEAYA Announces Agenda for Investor R&D Day Webcast on December 16, 2024

PR NewswireDec 11 06:00 ET

Express News | IDEAYA Announces First-Patient-in for Phase 1 Clinical Trial Evaluating Ide161 in Combination With Keytruda® (Pembrolizumab) in Patients With Endometrial Cancer

ReutersDec 10 06:00 ET

IDEAYA Biosciences Nominates IDE892 as Development Candidate

MT NewswiresDec 9 08:33 ET

Express News | IDEAYA Biosciences Inc -Ind-Enabling Studies Ongoing and Targeting Ind-Filing for Ide892 in Mid-2025

ReutersDec 9 06:06 ET

Express News | IDEAYA Biosciences Announces Development Candidate Nomination of Ide892, a Potential Best-in-Class Mta-Cooperative Prmt5 Inhibitor

ReutersDec 9 06:06 ET